Australia MedTech Market Growth, Demand and Challenges of the Key Industry Players 2024-32
                     Australia MedTech 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  t o  the  la tes t  r epo r t  by  I MARC Group,  t i t l ed  " Aust ra l ia  MedTech  
Market :  Indust ry  Trends ,  Share ,  S i ze ,  Growth ,  Opportun i ty  and  Forecast  
2024-2032 , "  t he  Aus t ra l ia  MedTech  marke t  s i ze  reached US$ 8 . 0  B i l l i on  in  2023 .
MedTech ,  a lso  known as  med ica l  t echno logy ,  i s  a  comb ina t i on  o f  t echno logy  and  
Report med ica l  i n t e r ven t i ons  t ha t  he lp  pa t i en ts  overcome in ju r ies  and chron ic  i l l nesses .  
I t  re l i es  on  var ious  med ica l  dev ices ,  such  as  tongue  depresso rs ,  su rg ica l  g loves ,  
Highlight and t hermomet ers ,  i nsu l i n  pumps ,  and  pacemakers .  I t  a l so  inc ludes  labo ra to ry  and  imag ing  tes t s ,  l i ke  CT scans ,  b iopsy ,  endoscopy ,  
u l t rasound,  and  b lood and u r ine  tes ts .  I t  he lps  acce le ra te  pa t ien t  recovery  and  
Description keeps  peop le  hea l thy .  A t  p resen t ,  MedTech  i s  w ide ly  used  in  t he  hea l t hcare  
indus t ry  f o r  pe r fo rm ing  numerous  c l in i ca l  and  non-c l in i ca l  app l i ca t ions  ac ross  
Aus t ra l ia .
Request  fo r  a  PDF sample  o f  th is  repor t :  
ht tps : / / www. imarcgroup .com/aus t ra l ia -med tech -marke t / reques tsample
Report Description
Austra l ia  MedTech  Market  T rends:
The  grow ing  preva lence o f  acu te  and chron ic  hea l th  cond i t i ons ,  espec ia l l y  among  the  ag ing  popu la t i on ,  r ep resen ts  
one o f  t he  key  fac t o r s  d r i v ing  the  marke t  in  Aus t ra l i a .  Add i t i ona l l y ,  t he  r i s ing  u t i l i za t ion  o f  hea l thca re  apps  and  
wearab le  dev ices  to  se l f -mon i t o r  hea r t  r a t e ,  g l ucose ,  and  b lood  p ressu re  i s  c rea t i ng  a  pos i t i ve  ou t look  fo r  t he  marke t  
in  t he  count ry .  A long  w i t h  t h i s ,  t he  inc reas ing  sa les  o f  t he  In te rne t  o f  Th ings  ( IoT ) - in tegra t ed  smar t wat ches  tha t  
ensu re  accu ra t e  m on i to r ing  o f  pa t ien t  hea l th  cond i t i ons  i s  s t r eng then ing  the  g rowt h  o f  t he  m arke t .  
The  r i s ing  adop t i on  o f  mob i le  hea l t h  (m-Hea l th )  se rv ices  fea t u r ing  ca l l  con f erenc ing  and  l i ve  consu l ta t i on  fac i l i t i es  
w i th  hea l t hca re  p ro f ess iona ls  i s  a lso  d r i v ing  the  marke t .  Fu r t he rmore ,  con t inuous  inves t ment  in  r esearch  and  
deve lopmen t  (R&D)  ac t i v i t i es  by  lead ing  MedTech  compan ies  o f  Aus t ra l ia  f o r  t he  deve lopmen t  o f  advanced  med ica l  
dev i ces  i s  acce le ra t ing  the  g rowt h  o f  t he  marke t .
Look ing  fo rward ,  the  market  va lue  i s  p ro jected  to  reach  US$  13 . 5  B i l l ion  by  2032,  expand i ng  at  a  CAG R o f  
6 . 03% dur i ng  2024-2032.
V i ew Report  TOC,  F igures and  Tab les :  h t tps: / / www. i marcgroup .com/aust ra l i a -medtech -market
Breakup by Type:
• Telehealth
• Medical  Wearables
• EMR/EHR Systems
• Medical  Apps
• Healthcare Analytics
• Others
Report 
Segmentation Breakup by Component:
• Software
• Hardware
• Service
Breakup by Deployment Type:
• On-Premises
• Cloud-Based
Breakup by Application:
• Cardiology
• Diabetes
• Neurology
Report • Sleep Apnea
Segmentation • Oncology
• Others
Breakup by End User:
• Healthcare Providers
• Healthcare Payers
• Pharmaceutical  Companies
Breakup by Region:
• Western Austral ia
• New South Wales
• Queensland
Report 
• Victoria
Segmentation • Rest of  Austral ia
• Alcidion Group Limited
• Anatomics Pty Ltd
• Artrya
Competitive • AusBiotech
• Avanade Austral ia (Accenture)
Landscape 
• Cochlear Limited
with Key • El lex
Players • ResMed Inc.
• Schott AG
• Sirtex Medical  L imited.
How has the Australia MedTech market performed 
so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the 
Australia MedTech market?
Key What are the key regional markets?
Questions 
Answered in What is the breakup of the market based on the type?
the Report
What is the breakup of the market based on the 
component?
What is the breakup of the market based on the 
deployment type?
What is the breakup of the market based on the 
application?
What is the breakup of the market based on the 
end user?
What are the various stages in the value chain of 
the industry?
Key What are the key driving factors and challenges in 
the industry?
Questions 
Answered in What is the structure of the Australia MedTech industry and who are the key players?
the Report
What is the degree of competition in the industry?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     A u s t r a l i a  M e d T e c h  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  T y p e  
    6 . 1     T e l e h e a l t h
        6 . 1 . 1  M a r k e t  T r e n d s  
        6 . 1 . 2  M a r k e t  F o r e c a s t          
    6 . 2     M e d i c a l  W e a r a b l e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t   
    6 . 3     E M R / E H R  S y s t e m s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     M e d i c a l  A p p s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     H e a l t h c a r e  A n a l y t i c s
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
    6 . 6     O t h e r s
        6 . 6 . 1  M a r k e t  T r e n d s
        6 . 6 . 2  M a r k e t  F o r e c a s t   
7    M a r k e t  B r e a k u p  b y  C o m p o n e n t
    7 . 1     S o f t w a r e
        7 . 1 . 1  M a r k e t  T r e n d s
Table of         7 . 1 . 2  M a r k e t  F o r e c a s t    7 . 2     H a r d w a r e
        7 . 2 . 1  M a r k e t  T r e n d s
Contents         7 . 2 . 2  M a r k e t  F o r e c a s t         7 . 3     S e r v i c e
        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  D e p l o y m e n t  T y p e
    8 . 1     O n - P r e m i s e s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     C l o u d - B a s e d
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
    9 . 1     C a r d i o l o g y
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /a us t ra l i a -m ed tec h -m a rke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: